265312-60-5 Usage
Description
4,7-Benzothiazoledione,5-methoxy-2-methyl-(9CI) is a chemical compound belonging to the benzothiazole family, characterized by a molecular formula of C9H7NO2S. This derivative features a methoxy substituent at the 5-position and a methyl group at the 2-position, which may contribute to its potential biological and pharmacological properties. Due to its potential applications in research and industry, it is essential to handle this compound with care and adhere to safety protocols.
Uses
Used in Pharmaceutical Research:
4,7-Benzothiazoledione,5-methoxy-2-methyl-(9CI) is used as a research compound for exploring its potential biological and pharmacological activities. Its unique structure may offer insights into the development of new drugs or therapeutic agents.
Used in Chemical Synthesis:
In the chemical industry, 4,7-Benzothiazoledione,5-methoxy-2-methyl-(9CI) may serve as an intermediate or building block in the synthesis of more complex molecules, contributing to the creation of novel compounds with specific applications.
Used in Material Science:
4,7-Benzothiazoledione,5-methoxy-2-methyl-(9CI)'s properties could be harnessed in material science for the development of new materials with unique characteristics, such as improved stability, reactivity, or selectivity in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 265312-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,5,3,1 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 265312-60:
(8*2)+(7*6)+(6*5)+(5*3)+(4*1)+(3*2)+(2*6)+(1*0)=125
125 % 10 = 5
So 265312-60-5 is a valid CAS Registry Number.
265312-60-5Relevant articles and documents
Benzimidazole- and benzothiazole-quinones: Excellent substrates for NAD(P)H:quinone oxidoreductase 1
Newsome, Jeffery J.,Colucci, Marie A.,Hassani, Mary,Beall, Howard D.,Moody, Christopher J.
, p. 3665 - 3673 (2008/09/21)
A series of benzimidazole- and benzothiazole-quinones has been synthesized. The ability of these heterocyclic quinones to act as substrates for recombinant human NAD(P)H:quinone oxidoreductase (NQO1), a two-electron reductase upregulated in tumour cells,
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents
Ryu, Chung-Kyu,Kang, Hye-Young,Lee, Sang Kook,Nam, Kyung Ae,Hong, Chang Yong,Ko, Won-Gil,Lee, Byung-Hoon
, p. 461 - 464 (2007/10/03)
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles were synthesized as inhibitors of cyclin-dependent kinase 4 (CDK4) and cytotoxic agents. Most of the 4,7-dioxobenzothiazoles exhibited selective inhibitory activities for the CDK4 and cytotoxic potential agains
